Učitavanje...

Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction

Beraprost is used to treat peripheral chronic arterial occlusive disease. However, the efficacy and safety of beraprost in patients with pulmonary hypertension (PH) due to left ventricular systolic dysfunction (PH-HFrEF) remains unknown. The primary objective of this study was to determine the effec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Medicine (Baltimore)
Glavni autori: Wang, Li, Zhu, Xinyi, Zhao, Liang-Ping, Wang, Maosong, Liu, Xiang, Chen, Yuqi, Chen, JianChang, Xu, WeiTing
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494404/
https://ncbi.nlm.nih.gov/pubmed/31008926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014965
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!